Literature DB >> 11519374

Applying cost analysis methods to school-based prevention programs.

P Chatterji1, C M Caffray, A S Jones, M Lillie-Blanton, L Werthamer.   

Abstract

In order to efficiently allocate scarce prevention resources, policymakers need information about the economic costs of school-based substance use prevention programs. The objective of this paper is to outline economic cost analysis methods and demonstrate their applicability to school-based prevention programs. As an example, the paper focuses on estimating the economic cost of ALPHA, an intensive school-based substance use prevention program. The cost of ALPHA is compared to the costs of 3 elementary school programs that were alternatives to ALPHA. We collected cost information for 3 years, using a cost questionnaire that was completed by program and school budget officers and school principals. The program costs obtained from these sources were modified to conform to well-established economic cost analysis principles.

Mesh:

Year:  2001        PMID: 11519374     DOI: 10.1023/a:1010086928908

Source DB:  PubMed          Journal:  Prev Sci        ISSN: 1389-4986


  6 in total

1.  Estimating the economic cost of substance abuse treatment.

Authors:  M T French; K A McGeary
Journal:  Health Econ       Date:  1997 Sep-Oct       Impact factor: 3.046

2.  Implementing drug education in schools: an analysis of the costs and teacher perceptions.

Authors:  R Tricker; L G Davis
Journal:  J Sch Health       Date:  1988-05       Impact factor: 2.118

3.  How effective is drug abuse resistance education? A meta-analysis of Project DARE outcome evaluations.

Authors:  S T Ennett; N S Tobler; C L Ringwalt; R L Flewelling
Journal:  Am J Public Health       Date:  1994-09       Impact factor: 9.308

4.  Cost-effectiveness analysis of an educational drug abuse prevention program.

Authors:  M E Mitchel; T W Hu; N S McDonnell; J D Swisher
Journal:  J Drug Educ       Date:  1984

5.  The effectiveness of Drug Abuse Resistance Education (project DARE): 5-year follow-up results.

Authors:  R R Clayton; A M Cattarello; B M Johnstone
Journal:  Prev Med       Date:  1996 May-Jun       Impact factor: 4.018

6.  Characteristics of health education among secondary schools--School Health Education Profiles, 1996.

Authors:  J A Grunbaum; L Kann; B I Williams; S A Kinchen; J L Collins; L J Kolbe
Journal:  MMWR CDC Surveill Summ       Date:  1998-09-11
  6 in total
  7 in total

Review 1.  Critical issues in the prevention of violence-related behavior in youth.

Authors:  Suzanne E U Kerns; Ronald J Prinz
Journal:  Clin Child Fam Psychol Rev       Date:  2002-06

2.  Standards of evidence: criteria for efficacy, effectiveness and dissemination.

Authors:  Brian R Flay; Anthony Biglan; Robert F Boruch; Felipe González Castro; Denise Gottfredson; Sheppard Kellam; Eve K Mościcki; Steven Schinke; Jeffrey C Valentine; Peter Ji
Journal:  Prev Sci       Date:  2005-09

3.  Enhancing the net benefits of disseminating efficacious prevention programs: a note on target efficiency with illustrative examples.

Authors:  David S Salkever; Stephen Johnston; Mustafa C Karakus; Nicholas S Ialongo; Eric P Slade; Elizabeth A Stuart
Journal:  Adm Policy Ment Health       Date:  2008-03-15

4.  Multisite cost analysis of a school-based voluntary alcohol and drug prevention program.

Authors:  Beau Kilmer; James R Burgdorf; Elizabeth J D'Amico; Jeremy Miles; Joan Tucker
Journal:  J Stud Alcohol Drugs       Date:  2011-09       Impact factor: 2.582

5.  Nurse Family Partnership: Comparing Costs per Family in Randomized Trials Versus Scale-Up.

Authors:  Ted R Miller; Delia Hendrie
Journal:  J Prim Prev       Date:  2015-12

6.  Did we get our money's worth? Bridging economic and behavioral measures of program success in adolescent drug prevention.

Authors:  Kevin N Griffith; Lawrence M Scheier
Journal:  Int J Environ Res Public Health       Date:  2013-11-08       Impact factor: 3.390

7.  Reducing disability via a family centered intervention for acutely ill persons with Alzheimer's disease and related dementias: protocol of a cluster-randomized controlled trial (Fam-FFC study).

Authors:  Marie Boltz; Ashley Kuzmik; Barbara Resnick; Rebecca Trotta; Jacqueline Mogle; Rhonda BeLue; Douglas Leslie; James E Galvin
Journal:  Trials       Date:  2018-09-17       Impact factor: 2.728

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.